Neuberger Berman Group
BNTX icon

Neuberger Berman Group’s BioNTech BNTX Stock Holding History

Neuberger Berman Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,872
Closed -$1.2M – 1939
2024
Q2 		$1.2M Sell
14,872
-440
-3% -$40.2K ﹤0.01% 1221
2024
Q1 		$1.41M Buy
15,312
+512
+3% +$49.1K ﹤0.01% 1197
2023
Q4 		$1.56M Buy
+14,800
New +$1.49M ﹤0.01% 1167
2022
Q1 		– Sell
-1,155
Closed -$311K – 1909
2021
Q4 		$311K Buy
+1,155
New +$316K ﹤0.01% 1715

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Neuberger Berman Group's BNTX Position: Q3 2024 in Review

Neuberger Berman Group sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 14,872 shares — an estimated $1.2M sold.

Neuberger Berman Group first reported a position in BNTX in Q4 2021 and held it in 4 quarters. The position peaked at $1.56M in Q4 2023. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Neuberger Berman Group reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Neuberger Berman Group sold 14,872 BioNTech shares in Q3 2024, an estimated $1.2M.
  • Neuberger Berman Group first reported a position in BioNTech in Q4 2021 and held it in 4 quarters.
  • Neuberger Berman Group's BioNTech position peaked at $1.56M in Q4 2023.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Neuberger Berman Group's 13F filing for Q3 2024, filed 14 Nov 2024.